SmithRx Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 550

Employees

  • Latest Deal Type
  • Series C

  • Latest Deal Amount
  • $60M

  • Investors
  • 19

SmithRx General Information

Description

Developer of a pharmacy benefit manager platform designed to focus on transparency, efficiency, and data analytics. The company's system offers flexibility, control, and visibility of pharmacy benefits data for employer customers and partners, enabling members to benefit from the company's clinical programs, alternative sourcing, and transparent pricing to easily manage their prescription benefits and reduce overall drug spending.

Contact Information

Website
www.smithrx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 300 Brannan Street
  • Suite 601
  • San Francisco, CA 94107
  • United States
+1 (844)
Primary Industry
Other Healthcare Technology Systems
Other Industries
Other Healthcare Services
Vertical(s)
Corporate Office
  • 300 Brannan Street
  • Suite 601
  • San Francisco, CA 94107
  • United States
+1 (844)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SmithRx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series C) 23-Jan-2024 $60M Completed Generating Revenue
6. Later Stage VC (Series B) 02-Feb-2022 Completed Generating Revenue
5. Debt - PPP 16-Apr-2020 Completed Generating Revenue
4. Early Stage VC (Series A2) 31-Jul-2018 Completed Generating Revenue
3. Debt - General 01-May-2018 Completed Generating Revenue
2. Early Stage VC (Series A) 11-Jan-2018 $9M $12M Completed Generating Revenue
1. Seed Round 31-Mar-2017 $3M $3M Completed Generating Revenue
To view SmithRx’s complete valuation and funding history, request access »

SmithRx Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C
Series B2
Series B1
Series B
Series A2
Series A1 3,160,387 $0.000100 $0.08 $0.97 $0.97 1x $0.97 3.25%
Series A 6,730,467 $0.000100 $0.11 $1.34 $1.34 1x $1.34 6.93%
To view SmithRx’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

SmithRx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a pharmacy benefit manager platform designed to focus on transparency, efficiency, and data analytics. The
Other Healthcare Technology Systems
San Francisco, CA
550 As of 2024

Wilmington, DE
 

New York, NY
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

SmithRx Competitors (25)

One of SmithRx’s 25 competitors is Truveris, a Venture Capital-Backed company based in Wilmington, DE.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Truveris Venture Capital-Backed Wilmington, DE
Rightway Venture Capital-Backed New York, NY
MEDecision Formerly VC-backed Dallas, TX
Health Catalyst Formerly VC-backed South Jordan, UT
Judi Health Venture Capital-Backed New York, NY
You’re viewing 5 of 25 competitors. Get the full list »

SmithRx Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SmithRx Investors (19)

Investor Name Investor Type Holding Investor Since Participating Rounds
10X Group Angel Group Minority
Gaingels Venture Capital Minority
Venrock Venture Capital Minority
Four Cities Capital Venture Capital Minority
Angel (individual) Minority
You’re viewing 5 of 19 investors. Get the full list »

SmithRx Acquisitions (2)

SmithRx’s most recent deal was a Merger/Acquisition with WithMe Health. The deal was made on 01-Jan-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
WithMe Health 01-Jan-2024 Merger/Acquisition Enterprise Systems (Healthcare)
WhiteWell Rx 10-Jan-2017 Merger/Acquisition Pharmaceuticals
To view SmithRx’s complete acquisitions history, request access »

SmithRx FAQs

  • When was SmithRx founded?

    SmithRx was founded in 2016.

  • Where is SmithRx headquartered?

    SmithRx is headquartered in San Francisco, CA.

  • What is the size of SmithRx?

    SmithRx has 550 total employees.

  • What industry is SmithRx in?

    SmithRx’s primary industry is Other Healthcare Technology Systems.

  • Is SmithRx a private or public company?

    SmithRx is a Private company.

  • What is the current valuation of SmithRx?

    The current valuation of SmithRx is .

  • What is SmithRx’s current revenue?

    The current revenue for SmithRx is .

  • How much funding has SmithRx raised over time?

    SmithRx has raised $110M.

  • Who are SmithRx’s investors?

    10X Group, Gaingels, Venrock, Four Cities Capital, and are 5 of 19 investors who have invested in SmithRx.

  • Who are SmithRx’s competitors?

    Truveris, Rightway, MEDecision, Health Catalyst, and Judi Health are some of the 25 competitors of SmithRx.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process